Geert Vanden Bossche, PhD | Mass Vaccination in a Pandemic: Benefits vs. Risks

Geert Vanden Bossche, PhD | Mass Vaccination in a Pandemic: Benefits vs. Risks

User Photo
Nikon the Meganoite

3 months
5 Views
Share Download
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
March 6, 2021
Geert Vanden Bossche, PhD, is an internationally recognized vaccine developer having worked as the head of the Vaccine Development Office at the German Centre for Infection Research.
Dr. Bossche coordinated the Global Alliance for Vaccines and Immunization's Ebola Vaccine Program and contributed to the implementation of an integrated vaccine work plan in collaboration with Global Health Partners (WHO, Bill & Melinda Gates Foundation, CDC, UNICEF), regulators (FDA), and vaccine manufacturers to enable timely deployment or stockpiling of Ebola vaccine candidates.
He discusses the principles of using a prophylactic vaccine in the midst of a pandemic and how the vaccines are likely to create more viral variants in the process and shares his perspective on COVID-19 mass vaccination.

Comments:

Comment
Up Next Autoplay